Biotech R&D Platform Benchling Closes $100M at $6B Valuation
HIT Consultant
NOVEMBER 18, 2021
Benchling’s growth is fueled by the rapid rise of biotechnology , one of the world’s fastest-growing industries. As biotechnology companies come under increased pressure to deliver breakthroughs, they are turning to modern software to digitize all their scientific processes and centralize their data. Recent Traction/Milestones.
Let's personalize your content